caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1952326845

Ziad RifaiMD

NeurologyGeneva, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Ziad Rifai's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 22 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Scott Mooney
Diagnostic Radiology · Geneva, NY
69134
SOLDIERS & SAILORS MEMORIAL HOSPITAL50138
RAO, RAMANI4886
Thomas Thompson
Diagnostic Radiology · Geneva, NY
4167
Rodolfo Queiroz
Diagnostic Radiology · Geneva, NY
3347
Arthur Equinozzi
Internal Medicine · Penn Yan, NY
2874
William Platzer
Internal Medicine · Geneva, NY
1946
CLIFTON SPRINGS SANITARIUM CO1946
Emily Lambert
Dermatology · Geneva, NY
1854
STOUT, RICHARD1836
UNIVERSITY OF ROCHESTER1523
Helen Wong
Orthopedic Surgery · Geneva, NY
1419
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
634
Unique beneficiaries
—
Total services
768
Distinct HCPCS
10
Medicare payment
$71K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,430 Neurology providers in NY — above median (cohort median 560).
QUALITY · MIPS · 2024
Final MIPS score
77.1
Quality
53.0
Cost
69.6
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.09%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
6,429
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
57
Brand share
27.0%
Top prescribed drugs
Donepezil Hcl840 claims
Lamotrigine685 claims
Levetiracetam472 claims
Memantine Hcl403 claims
Topiramate360 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$790
Payment records
49
By payment type
Food and Beverage$790